VanEck Pharmaceutical ETF (PPH) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
VanEck Pharmaceutical ETF (PPH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $603.0M, listed on NASDAQ, carrying a beta of 0.46 to the broader market. VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. public since 2000-02-01.
Snapshot as of May 15, 2026.
- Spot Price
- $100.86
- ATM IV
- 20.4%
- IV Skew 25Δ
- 0.045
- IV Rank
- 36.4%
- IV Percentile
- 50.8%
- Term Structure Slope
- -0.002
As of May 15, 2026, VanEck Pharmaceutical ETF (PPH) at-the-money implied volatility is 20.4%. IV rank is 36.4% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 50.8%. The 25-delta skew is +0.045: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
PPH Strategy Selection at Current Volatility Levels
For VanEck Pharmaceutical ETF options at 20.4% ATM IV, mid-range IV rank (36.4%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked PPH volatility skew questions
- What is the current PPH ATM implied volatility?
- As of May 15, 2026, VanEck Pharmaceutical ETF (PPH) at-the-money implied volatility is 20.4%. IV rank is 36.4% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is PPH IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does PPH volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. VanEck Pharmaceutical ETF shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.